Tocilizumab vs. anti-TNFα agents for resolution of uveitic macular edema

This retrospective study assessed the efficacy and safety of tocilizumab and anti–tumor necrosis factor alpha (TNFα) agent for the control of ocular inflammation in patients with noninfectious uveitis and macular edema (ME).
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553